Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Claxton

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|February 5, 2008
Value based pricing for NHS drugs: an opportunity not to be missed?Karl Claxton, Andrew Briggs, Martin J Buxton, et al.
BMJ Global Health|January 8, 2019
Appraising the value of evidence generation activities: an HIV modelling studyBeth Woods, Claire Rothery, Sarah-Jane Anderson, et al.
BMJ (Clinical Research Ed.)|March 8, 2003
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosisJim Chilcott, Chris McCabe, Paul Tappenden, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2009
Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendationsHelen Weatherly, Michael Drummond, Karl Claxton, et al.
Health Technology Assessment (Winchester, England)|February 19, 2015
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdKarl Claxton, Steve Martin, Marta Soares, et al.
BMJ (Clinical Research Ed.)|September 13, 2007
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analysesTim E Colbourn, Christian Asseburg, Laura Bojke, et al.
Health Technology Assessment (Winchester, England)|June 9, 2021
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods studyLaura Bojke, Marta Soares, Karl Claxton, et al.
The Lancet. Global Health|September 21, 2023
Challenges of calculating cost-effectiveness thresholdsLaura Vallejo-Torres, Karl Claxton, Laura C Edney, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 17, 2021
Reference Case Methods for Expert Elicitation in Health Care Decision MakingLaura Bojke, Marta O Soares, Karl Claxton, et al.
International Journal of Technology Assessment in Health Care|April 16, 2010
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United KingdomClaire McKenna, Neil Hawkins, Karl Claxton, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|February 5, 2008
Value based pricing for NHS drugs: an opportunity not to be missed?Karl Claxton, Andrew Briggs, Martin J Buxton, et al.
BMJ Global Health|January 8, 2019
Appraising the value of evidence generation activities: an HIV modelling studyBeth Woods, Claire Rothery, Sarah-Jane Anderson, et al.
BMJ (Clinical Research Ed.)|March 8, 2003
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosisJim Chilcott, Chris McCabe, Paul Tappenden, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2009
Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendationsHelen Weatherly, Michael Drummond, Karl Claxton, et al.
Health Technology Assessment (Winchester, England)|February 19, 2015
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdKarl Claxton, Steve Martin, Marta Soares, et al.
BMJ (Clinical Research Ed.)|September 13, 2007
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analysesTim E Colbourn, Christian Asseburg, Laura Bojke, et al.
Health Technology Assessment (Winchester, England)|June 9, 2021
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods studyLaura Bojke, Marta Soares, Karl Claxton, et al.
The Lancet. Global Health|September 21, 2023
Challenges of calculating cost-effectiveness thresholdsLaura Vallejo-Torres, Karl Claxton, Laura C Edney, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 17, 2021
Reference Case Methods for Expert Elicitation in Health Care Decision MakingLaura Bojke, Marta O Soares, Karl Claxton, et al.
International Journal of Technology Assessment in Health Care|April 16, 2010
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United KingdomClaire McKenna, Neil Hawkins, Karl Claxton, et al.
Pageof 12